[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Global Kidney Fibrosis Treatment Market Size study & Forecast, by Therapeutics (Angiotensin II receptor blockers (ARBs), Angiotensin Converting Enzyme (ACE) inhibitors, Pirfenidone, Renin Inhibitors, Vasopeptidase Inhibitors), by End User (hospital, Clinics, Home Treatment) and Regional Analysis, 2022-2029

October 2022 | 200 pages | ID: G55D7CDCD7EDEN
Bizwit Research & Consulting LLP

US$ 4,950.00

E-mail Delivery (PDF), Hard Copy Mail Delivery

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
Global Kidney Fibrosis Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Kidney Fibrosis refers to excessive production and deposition of extracellular matrix (ECM) proteins in the kidney interstitium. This excessive production and deposition of ECM causes structural damage, impairment of renal function, and leads to end-stage renal disease (ESRD). Diabetes and Hypertension are two leading causes of Kidney Fibrosis. Apart from these two as infectious glomerulonephritis, renal vasculitis, ureteral obstruction, genetic alterations, and autoimmune diseases among others also causes Kidney Fibrosis. The increasing incidence of chronic kidney diseases and rowing awareness towards renal fibrosis treatment as well as strategic initiatives from leading market player are key factors accelerating the market growth.

According to the Centers for Disease Control & Prevention – as of 2021, around 37 million US individual are affected by chronic kidney diseases, witnessing for over 15% of all US adults. Moreover, as per National Kidney Foundation estimates- in the United States more than 1 in 7 adults are diagnosed with chronic kidney disease. In addition, around 90% of individuals with kidney disease are not aware about their disease. Also, rising number of favorable initiatives from government authorities and increasing prevalence of lifestyle diseases would create lucrative growth prospectus for the market over the forecast period. However, complex process associated with regulatory approvals stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Kidney Fibrosis Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America the leading region in terms of market share owing to increasing prevalence of chronic kidney diseases as well as favorable initiatives from government authorities in the region. Whereas Asia Pacific is expected to grow significantly during the forecast period, owing to factors such as rising healthcare spending as well as growing prevalence of lifestyle diseases such as hypertension and diabetes in the region.

Major market player included in this report are:
Merck & Co.
F. Hoffman-La Roche Ltd.
Pfizer Inc.
Galectin Therapeutics
La Jolla Pharmaceutical Company
InterMune Inc.
ProMetic Life-Sciences Inc.
Genzyme Corporation
BioLine Rx Ltd
Certa Therapeutics
Recent Developments in the Market:
In March 2022, Zydus Lifesciences received approval for its New Drug Application (NDA) named Oxemia from the Drug Controller General of India (DCGI). The new drug Oxemia, would be a first-of-its-kind oral treatment in India for anaemia associated with chronic kidney disease (CKD)

In August 2022, Bayer launched a new drug named finerenone for treatment of chronic kidney disease associated with type-2 diabetes in India. This new drug would be sold in India under brand name Kerendia.


In August 2022, USA based Children’s Hospital of Philadelphia (CHOP) and Penn Medicine jointly announced the launch of Penn-CHOP Kidney Innovation Center. This new center would be first-of-its-kind and would work towards advance research for the early detection, prevention, and treatment of kidney disease and its associated complications.


Global Kidney Fibrosis Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Therapeutics, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Therapeutics
Angiotensin II receptor blockers (ARBs)
Angiotensin Converting Enzyme (ACE) inhibitors
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors
By End User
Hospital
Clinics
Home Treatment

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
CHAPTER 1. EXECUTIVE SUMMARY

1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
  1.2.1. Kidney Fibrosis Treatment Market, by Region, 2019-2029 (USD Billion)
  1.2.2. Kidney Fibrosis Treatment Market, by Therapeutics, 2019-2029 (USD Billion)
  1.2.3. Kidney Fibrosis Treatment Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption

CHAPTER 2. GLOBAL KIDNEY FIBROSIS TREATMENT MARKET DEFINITION AND SCOPE

2.1. Objective of the Study
2.2. Market Definition & Scope
  2.2.1. Scope of the Study
  2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates

CHAPTER 3. GLOBAL KIDNEY FIBROSIS TREATMENT MARKET DYNAMICS

3.1. Kidney Fibrosis Treatment Market Impact Analysis (2019-2029)
  3.1.1. Market Drivers
    3.1.1.1. Increasing incidence of chronic kidney diseases.
    3.1.1.2. Growing awareness towards renal fibrosis treatment.
    3.1.1.3. Strategic initiatives from leading market players.
  3.1.2. Market Challenges
    3.1.2.1. Complex regulatory approval procedures.
  3.1.3. Market Opportunities
    3.1.3.1. Increasing number of favourable initiatives from government authorities.
    3.1.3.2. Rising prevalence of lifestyle diseases.

CHAPTER 4. GLOBAL KIDNEY FIBROSIS TREATMENT MARKET INDUSTRY ANALYSIS

4.1. Porter’s 5 Force Model
  4.1.1. Bargaining Power of Suppliers
  4.1.2. Bargaining Power of Buyers
  4.1.3. Threat of New Entrants
  4.1.4. Threat of Substitutes
  4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
  4.3.1. Political
  4.3.2. Economical
  4.3.3. Social
  4.3.4. Technological
4.4. Investment Adoption Model
4.5. Analyst Recommendation & Conclusion
4.6. Top investment opportunity
4.7. Top winning strategies

CHAPTER 5. RISK ASSESSMENT: COVID-19 IMPACT

5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario

CHAPTER 6. GLOBAL KIDNEY FIBROSIS TREATMENT MARKET, BY THERAPEUTICS

6.1. Market Snapshot
6.2. Global Kidney Fibrosis Treatment Market by Therapeutics, Performance - Potential Analysis
6.3. Global Kidney Fibrosis Treatment Market Estimates & Forecasts by Therapeutics 2019-2029 (USD Billion)
6.4. Kidney Fibrosis Treatment Market, Sub Segment Analysis
  6.4.1. Angiotensin II receptor blockers (ARBs)
  6.4.2. Angiotensin Converting Enzyme (ACE) inhibitors
  6.4.3. Pirfenidone
  6.4.4. Renin Inhibitors
  6.4.5. Vasopeptidase Inhibitors

CHAPTER 7. GLOBAL KIDNEY FIBROSIS TREATMENT MARKET, BY END USER

7.1. Market Snapshot
7.2. Global Kidney Fibrosis Treatment Market by End User, Performance - Potential Analysis
7.3. Global Kidney Fibrosis Treatment Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
7.4. Kidney Fibrosis Treatment Market, Sub Segment Analysis
  7.4.1. Hospital
  7.4.2. Clinics
  7.4.3. Home Treatment

CHAPTER 8. GLOBAL KIDNEY FIBROSIS TREATMENT MARKET, REGIONAL ANALYSIS

8.1. Kidney Fibrosis Treatment Market, Regional Market Snapshot
8.2. North America Kidney Fibrosis Treatment Market
  8.2.1. U.S. Kidney Fibrosis Treatment Market
    8.2.1.1. Therapeutics breakdown estimates & forecasts, 2019-2029
    8.2.1.2. End User breakdown estimates & forecasts, 2019-2029
  8.2.2. Canada Kidney Fibrosis Treatment Market
8.3. Europe Kidney Fibrosis Treatment Market Snapshot
  8.3.1. U.K. Kidney Fibrosis Treatment Market
  8.3.2. Germany Kidney Fibrosis Treatment Market
  8.3.3. France Kidney Fibrosis Treatment Market
  8.3.4. Spain Kidney Fibrosis Treatment Market
  8.3.5. Italy Kidney Fibrosis Treatment Market
  8.3.6. Rest of Europe Kidney Fibrosis Treatment Market
8.4. Asia-Pacific Kidney Fibrosis Treatment Market Snapshot
  8.4.1. China Kidney Fibrosis Treatment Market
  8.4.2. India Kidney Fibrosis Treatment Market
  8.4.3. Japan Kidney Fibrosis Treatment Market
  8.4.4. Australia Kidney Fibrosis Treatment Market
  8.4.5. South Korea Kidney Fibrosis Treatment Market
  8.4.6. Rest of Asia Pacific Kidney Fibrosis Treatment Market
8.5. Latin America Kidney Fibrosis Treatment Market Snapshot
  8.5.1. Brazil Kidney Fibrosis Treatment Market
  8.5.2. Mexico Kidney Fibrosis Treatment Market
8.6. Rest of The World Kidney Fibrosis Treatment Market

CHAPTER 9. COMPETITIVE INTELLIGENCE

9.1. Top Market Strategies
9.2. Company Profiles
  9.2.1. Merck & Co.
    9.2.1.1. Key Information
    9.2.1.2. Overview
    9.2.1.3. Financial (Subject to Data Availability)
    9.2.1.4. Product Summary
    9.2.1.5. Recent Developments
  9.2.2. F. Hoffman-La Roche Ltd.
  9.2.3. Pfizer Inc
  9.2.4. Galectin Therapeutics
  9.2.5. La Jolla Pharmaceutical Company
  9.2.6. InterMune Inc.
  9.2.7. ProMetic Life-Sciences Inc.
  9.2.8. Genzyme Corporation
  9.2.9. BioLine Rx Ltd
  9.2.10. Certa Therapeutics

CHAPTER 10. RESEARCH PROCESS

10.1. Research Process
  10.1.1. Data Mining
  10.1.2. Analysis
  10.1.3. Market Estimation
  10.1.4. Validation
  10.1.5. Publishing
10.2. Research Attributes
10.3. Research Assumption
LIST OF TABLES

TABLE 1. Global Kidney Fibrosis Treatment Market, report scope
TABLE 2. Global Kidney Fibrosis Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Kidney Fibrosis Treatment Market estimates & forecasts by Therapeutics 2019-2029 (USD Billion)
TABLE 4. Global Kidney Fibrosis Treatment Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 5. Global Kidney Fibrosis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 6. Global Kidney Fibrosis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Kidney Fibrosis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Kidney Fibrosis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Kidney Fibrosis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Kidney Fibrosis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Kidney Fibrosis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Kidney Fibrosis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Kidney Fibrosis Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Kidney Fibrosis Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. U.S. Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 17. U.S. Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. Canada Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 19. Canada Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 20. Canada Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. UK Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 22. UK Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 23. UK Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. Germany Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 25. Germany Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 26. Germany Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. France Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 28. France Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 29. France Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. Italy Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 31. Italy Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 32. Italy Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Spain Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 34. Spain Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 35. Spain Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. RoE Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 37. RoE Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 38. RoE Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. China Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 40. China Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 41. China Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. India Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 43. India Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 44. India Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. Japan Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 46. Japan Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 47. Japan Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. South Korea Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 49. South Korea Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 50. South Korea Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. Australia Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 52. Australia Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 53. Australia Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. RoAPAC Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 55. RoAPAC Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 56. RoAPAC Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. Brazil Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 58. Brazil Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 59. Brazil Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Mexico Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 61. Mexico Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 62. Mexico Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. RoLA Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 64. RoLA Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 65. RoLA Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. Row Kidney Fibrosis Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 67. Row Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 68. Row Kidney Fibrosis Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. List of secondary sources, used in the study of global Kidney Fibrosis Treatment Market
TABLE 70. List of primary sources, used in the study of global Kidney Fibrosis Treatment Market
TABLE 71. Years considered for the study
TABLE 72. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
LIST OF FIGURES

FIG 1. Global Kidney Fibrosis Treatment Market, research methodology
FIG 2. Global Kidney Fibrosis Treatment Market, Market estimation techniques
FIG 3. Global Market size estimates & forecast methods
FIG 4. Global Kidney Fibrosis Treatment Market, key trends 2021
FIG 5. Global Kidney Fibrosis Treatment Market, growth prospects 2022-2029
FIG 6. Global Kidney Fibrosis Treatment Market, porters 5 force model
FIG 7. Global Kidney Fibrosis Treatment Market, pest analysis
FIG 8. Global Kidney Fibrosis Treatment Market, value chain analysis
FIG 9. Global Kidney Fibrosis Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 10. Global Kidney Fibrosis Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 11. Global Kidney Fibrosis Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 12. Global Kidney Fibrosis Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 13. Global Kidney Fibrosis Treatment Market by segment, 2019 & 2029 (USD Billion)
FIG 14. Global Kidney Fibrosis Treatment Market, regional snapshot 2019 & 2029
FIG 15. North America Kidney Fibrosis Treatment Market 2019 & 2029 (USD Billion)
FIG 16. Europe Kidney Fibrosis Treatment Market 2019 & 2029 (USD Billion)
FIG 17. Asia pacific Kidney Fibrosis Treatment Market 2019 & 2029 (USD Billion)
FIG 18. Latin America Kidney Fibrosis Treatment Market 2019 & 2029 (USD Billion)
FIG 19. Global Kidney Fibrosis Treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable


More Publications